A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 1 953,97 kr, with a 24-hour trading volume of 5,32B kr. The asset's market cap is 3,02T kr, after moving 0.15% in the last day.
Tokenized AstraZeneca PLC is trading at 939,07 kr, with a tokenized market cap of 7,04M kr and a 24-hour trading volume of 6,17M kr. The tokenized asset has moved -1.03% in the past 24 hours.